Cited by 508Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsCardiovascular and exercise physiology

Heart Failure With Preserved Ejection Fraction: Mechanisms, Clinical Features, and Therapies

Open access
Sharma, Kavita, Kass, David A.·2014·Circulation Research

Abstract

The clinical syndrome comprising heart failure (HF) symptoms but with a left ventricular ejection fraction (EF) that is not diminished, eg, HF with preserved EF, is increasingly the predominant form of HF in the developed world, and soon to reach epidemic proportions. It remains among the most challenging of clinical syndromes for the practicing clinician and scientist alike, with a multitude of proposed mechanisms involving the heart and other organs and complex interplay with common comorbidities. Importantly, its morbidity and mortality are on par with HF with reduced EF, and as the list of failed treatments continues to grow, HF with preserved EF clearly represents a major unmet medical need. The field is greatly in need of a more unified approach to its definition and view of the syndrome that engages integrative and reserve pathophysiology beyond that related to the heart alone. We need to reflect on prior treatment failures and the message this is providing, and redirect our approaches likely with a paradigm shift in how the disease is viewed. Success will require interactions between clinicians, translational researchers, and basic physiologists. Here, we review recent translational and clinical research into HF with preserved EF and give perspectives on its evolving demographics and epidemiology, the role of multiorgan deficiencies, potential mechanisms that involve the heart and other organs, clinical trials, and future directions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.115.302922

Cites

178 of 178 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cardiac myocyte hypertrophy and cardiac fibrosis are markedly prevalent in patients with HFpEF, as confirmed in a large, prospective analysis of HFpEF myocardial tissue.

    “Two pathological characteristics markedly prevalent in patients with HFpEF are cardiac myocyte hypertrophy and cardiac fibrosis, as confirmed in a large, prospective analysis of HFpEF myocardial tissue.8,9”

    From Reversal of contractile defects by mediating calcium homeostasis in human mini-heart models of heart failure with preserved ejection fraction (HFpEF) leads to first-in-human gene therapy clinical trial (2024) · cites this paper as [9]

    The Myocardial Abnormalities section reports increased collagen in HFpEF endomyocardial biopsy tissue, supporting the fibrosis finding. The Epidemiology section describes hypertrophied hearts, but the copy does not establish that cardiac myocyte hypertrophy and fibrosis were both confirmed in a large, prospective analysis of HFpEF myocardial tissue. Page numbers are unavailable in the indexed copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [6]Loffredo FS Nikolova AP Pancoast JR Lee RT Aging and diastolic dysfunction: Molecular pathways Circulation Research 2104 In Press PMC4094348 24951760
  2. [18]Quinones MA Zile MR Massie BM Kass DA Chronic heart failure: A report from the dartmouth diastole discourses Congest Heart Fail 2006 12 162 165 16760702
  3. [57]Lam CS Roger VL Rodeheffer RJ Bursi F Borlaug BA Ommen SR Kass DA Redfield MM Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from olmsted county, minnesota Circulation 2007 115 1982 1990 17404159 PMC2001291
  4. [95]Westermann D Kasner M Steendijk P Spillmann F Riad A Weitmann K Hoffmann W Poller W Pauschinger M Schultheiss HP Tschope C Role of left ventricular stiffness in heart failure with normal ejection fraction Circulation 2008 117 2051 2060 18413502

Cited by

Sorted by citations

Authors
Sharma, K., & Kass, D. A.
Affiliations
Johns Hopkins University (US)
Venue
Circulation Research
Published
2014-06-20
Volume
115
Issue
1
Pages
79-96
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2527933700
Cited by
508
References
178
Citations by year
2026: 21 · 2025: 21 · 2024: 42 · 2023: 31 · 2022: 36 · 2021: 48 · 2020: 53 · 2019: 44 · 2018: 53 · 2017: 63 · 2016: 42 · 2015: 43 · 2014: 10
FWCI
8.39
Type
journal article
Language
en
Open access
Locations
  • Circulation Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL114910, P01HL077180, R01HL119012, HL-077180, HL-119012, HL114910, T32HL007227)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords
heart failure with preserved ejection fraction, left ventricular ejection fraction, heart failure pathophysiology, multiple organ failure, heart failure epidemiology, translational research, clinical trials, unmet medical needs
MeSH terms
Diastole, Energy Metabolism, Exercise Therapy, Heart Failure, Humans, Hypertension, Pulmonary, Inflammation, Stroke Volume, Systole, Ventricular Function, Left, Cyclic GMP-Dependent Protein Kinases, Muscle, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review